More New Orleans meetings cancelled

Ongoing repairs and FEMA occupancy will close Convention Center through March

Written byJohn Dudley Miller
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Although New Orleans officials originally believed they could start welcoming conventioneers back to their city December 1, they have now cancelled all large conventions through March, including several scientific societies' annual meetings.

The New Orleans Convention and Visitors Bureau adjusted its deadline after the Federal Emergency Management Agency (FEMA) decided to take over the Convention Center as its headquarters through March. Conventions with 3,000 to 5,000 attendees or more generally need that space for exhibitors, according to Donna Karl, the bureau's Chicago-based vice president for client relations. In addition, she said, damage to the building won't be totally repaired until the end of December. The bureau will let smaller meetings take place in hotels starting January 1, Karl noted, and all hotels should be ready for occupancy 30 days from now.

Annual biomedical conferences that must now be rescheduled include the late-January meeting of the Society of Critical Care Medicine ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform